Carmen Guillén-Ponce (C Guillén-Ponce, Carmen Guillén)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Rocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, Rafael Álvarez, Teresa Macarulla, Maria C Riesco-Martinez, Helena Verdaguer, Carmen Guillén-Ponce, Martí Farrera-Sal, Rafael Moreno, Ana Mato-Berciano, Maria Victoria Maliandi, Silvia Torres-Manjon, Marcel Costa, Natalia Del Pozo, Jaime Martínez de Villarreal, Francisco X Real, Noemí Vidal, Gabriel Capella, Ramon Alemany, Emma Blasi, Carmen Blasco, Manel Cascalló, Ramón Salazar
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors. Journal for immunotherapy of cancer 10 (3) (2022)
Manuel Valladares-Ayerbes, Pilar García Alfonso, Jorge Muñoz Luengo, Paola Patricia Pimentel Caceres, Oscar Alfredo Castillo-Trujillo, María Del Rosario Vidal Tocino, Marta Llanos, Beatriz Llorente Ayala, Maria Luisa Limon Miron, Antonieta Salud, Luis Cirera Nogueras, Rocio Garcia-Carbonero, Maria Jose Safont, Esther Falco Ferrer, Jorge Aparicio, Maria Angeles Vicente Conesa, Carmen Guillén-Ponce, Paula Garcia-Teijido, Maria Begoña Medina Magan, Isabel Busquier, Mercedes Salgado, Ariadna Lloansí Vila, null null
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study. Cancers 14 (24) (2022)
Manuel Valladares-Ayerbes, Pilar García Alfonso, Jorge Muñoz Luengo, Paola Patricia Pimentel Caceres, Oscar Alfredo Castillo-Trujillo, María Del Rosario Vidal Tocino, Marta Llanos, Beatriz Llorente Ayala, Maria Luisa Limon Miron, Antonieta Salud, Luis Cirera Nogueras, Rocio Garcia-Carbonero, Maria Jose Safont, Esther Falco Ferrer, Jorge Aparicio, Maria Angeles Vicente Conesa, Carmen Guillén-Ponce, Paula Garcia-Teijido, Maria Begoña Medina Magan, Isabel Busquier, Mercedes Salgado, Ariadna Lloansí Vila, null null
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study. Cancers 14 (24) (2022)
Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Hasan Borazanci, Jaime Feliú-Batlle, Mariano Ponz-Sarvisé, David Gutierrez Abad, Paul E Oberstein, Angela Alistar, Andres Muñoz, Ravit Geva, Carmen Guillén-Ponce, Mercedes Salgado Fernandez, Amnon Peled, Marya F Chaney, Irit Gliko-Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein-Haras, Manuel Hidalgo
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (18) (2021)
Carmen Guillén-Ponce, E Lastra, I Lorenzo-Lorenzo, T Martín Gómez, R Morales Chamorro, Ana Beatriz Sanchez-Heras, R Serrano, M C Soriano Rodríguez, J L Soto, L Robles
SEOM clinical guideline on hereditary colorectal cancer (2019). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (2) (2020)
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, R García-Carbonero, P Garcia-Alfonso, E Aranda, E Elez, R López-López, Andres Cervantes, M Valladares, C Nadal, J M Viéitez, Carmen Guillén-Ponce, J Rodríguez, I Hernández, J L García, R Vega-Bravo, A Puime-Otin, J Martínez-Useros, L Del Puerto-Nevado, R Rincón, M Rodríguez-Remírez, F Rojo, J García-Foncillas
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Scientific reports 9 (1) (2019)
Manuel Benavides, Eduardo Díaz-Rubio, Alfredo Carrato, Albert Abad, Carmen Guillén-Ponce, Pilar Garcia-Alfonso, Silvia Gil, María Teresa Cano, María José Safont, Cristina Gravalos, José Luis Manzano, Antonio Sánchez, Julia Alcaide, Rafael López, Bartomeu Massutí, Javier Sastre, Eva Martínez, Pilar Escudero, Miguel Méndez, Enrique Aranda
Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials. ESMO open 4 (6) (2019)
A Borrero-Palacios, A Cebrián, M T Gómez Del Pulgar, R García-Carbonero, P Garcia-Alfonso, E Aranda, E Elez, R López-López, Andres Cervantes, M Valladares, C Nadal, J M Viéitez, Carmen Guillén-Ponce, J Rodríguez, I Hernández, J L García, R Vega-Bravo, A Puime-Otin, J Martínez-Useros, L Del Puerto-Nevado, R Rincón, M Rodríguez-Remírez, F Rojo, J García-Foncillas
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Scientific reports 9 (1) (2019)

Carmen Guillén-Ponce.css-eqlu8i{font-size:small;padding-left:4px;} (C Guillén-Ponce, Carmen Guillén)

Publication Activity (10 Years)

Top Topics

Top Venues

Carmen Guillén-Ponce (C Guillén-Ponce, Carmen Guillén)